Moderna, Inc.
MRNA · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $1.94B | $3.24B | −39.9% |
| Operating income | −$3.07B | −$3.94B | +22.1% |
| Net income | −$2.82B | −$3.56B | +20.8% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 6, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $1.31B | $1.02B | +29.2% |
| Operating income | $130M | −$260M | |
| Net income | $162M | −$200M |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Moderna's revenue in FY2025?
- $1.94B in FY2025 (Fiscal year ended Dec 31, 2025), −39.9% vs $3.24B a year earlier, per its 10-K filed Feb 2026.
- Was Moderna profitable in FY2025?
- No: net income was −$2.82B and operating income −$3.07B in FY2025.
- What was Moderna's revenue in Q3 2026?
- $1.31B (+29.2% vs a year earlier), per its Form 10-Q filed Nov 6, 2026.